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Sompolinsky et al. (7) proposed the name Mycobacterium haemophilum for a hitherto unrecognized mycobacterium isolated from subcutaneous granulomata in a 53-year-old Israeli woman receiving immunosuppressive treatment for Hodgkin's disease. The strain was unusual in its growth requirement for either hemin or hemoglobin. So far as is known, there have been no other recorded cases of infection with M. haemophilum.
Mezo et al. (3) presented the case histories of five patients from Sydney, Australia, with skin lesions caused by fastidious mycobacteria. Each patient was undergoing immunosuppressive therapy; four had received renal transplants, and the other had lymphocytic lymphoma. Although the cases had been recorded over a period of 9 years, the clinical and microbiological features of the lesions suggested that the same etiological agent was responsible in each case. The causative organism was isolated from the lesions of three patients, but only after the fortuitous discovery that it required a growth supplement of ferric ammonium citrate (FAC).
An apparently similar mycobacterium had been isolated at another Sydney Hospital (9) , also from skin lesions of a renal transplant patient. Because of the possibility that the isolates were identical with, or related to, M. haemophilum, we conducted comparative studies with a subculture of that organism.
Only three of the four isolates from Australian patients were available for further study, these being strains RM and OBJ from cases 4 and 5 as described by Mezo et al. (3) and strain POW, the isolate reported by Walder et al. (9) In sensitivity tests on Middlebrook 7H10 plus hemin, Sompolinsky et al. (7) found M. haemophilum to be sensitive to p-amino salicylic acid, whereas our results indicate probable resistance to that compound. Rifampin seems effective in vitro, although its clinical value remains to be proven. Sompolinsky et al. (8) investigated the serological properties of M. haemophilum by direct agglutination as well as by reaction with antibody-coated cells of Staphylococcus aureus. They found low degrees of cross-reactivity with some M. avium-M. intracellulare-M. scrofulaceum serovars, but absorption studies demonstrated the uniqueness of the surface antigens of M. haemophilum. The present study supports those observations and suggests that there might be only one serovar of M. haemophilum.
Increased awareness of the pathogenic potential of many species of mycobacteria has been the result of improved procedures for their primary isolation. So that M. haemophilum will be provided for, tuberculosis laboratories should include slopes of blood agar or LJ + FAC in the set of media for cultural examinations of skin lesions. In addition to M. haemophilum, M. chelonei and M. fortuitum will be isolated from skin lesions by general bacteriology laboratories if the incubation time for blood agar cultures is extended. Experiences with M. haemophilum give further support to the contention that a mycobacterial etiology must be considered in unexplained infective lesions.
M. haemophilum appears to be a potential pathogen of low virulence whose natural habitat is the environment. Although the only cases of infection recorded in Australia have occurred in a defined locality, i.e., Sydney, temporal features do not suggest communicability. Since each of the four renal transplant patients first developed lesions 5 to 6 months after surgery (3), an incubation period of 2 to 4 months seems most likely.
